GlucoTrack
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · New Jersey, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
301 State Rt 17 Ste 800, Rutherford, New...Phone Number
(201) 842-7715Website
www.glucotrack.comRevenue
-Stock Symbol
GCTKIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About GlucoTrack
GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. GlucoTrack, Inc is based in Rutherford, New Jersey.Explore more
GlucoTrack Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is GlucoTrack your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at GlucoTrack
Check out if GlucoTrack is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when GlucoTrack launches new products
Website visits: Recent activity has been detected on your website
Click to see if GlucoTrack had a recent Job posting/layoffs
Funding: Get notified immidiatlly once GlucoTrack has new funding data
Check if GlucoTrack has recently received funding, and reach out quickly before it becomes old news!
GlucoTrack, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on GlucoTrack recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to GlucoTrack
Compare insights from companies similar to GlucoTrack, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$5.9M
11-50
Private
-
2001
MK
Melanie KellyCorporate Administration, Intellectual Property Manager, Human Resources
Company Profile Activity
Activity Insights
GlucoTrack is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
GlucoTrack is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about GlucoTrack.
GlucoTrack financials insights
Gather financial insights about GlucoTrack, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Other Financing Round
$100K
2025
Private Equity
$20M
GlucoTrack Tech Stack
A closer look at the technologies used by GlucoTrack
See more technologies
Most Recent Scoops
Project
GlucoTrack is developing a fully implantable CGM system with no on-body wearable that lasts three years, compared to the one existing implantable device that lasts only one year and still requires an external wearable.
Product Development, Medical Research, Healthcare Technology
Project
GlucoTrack is developing a fully implantable CGM device with no on-body wearable, lasting for three years and measuring glucose directly in the blood. The device aims to overcome lag time issues during rapid glucose changes.
Product Development, Medical Research, Healthcare Technology
Project
GlucoTrack is developing a fully implantable continuous glucose sensor for diabetes management that lasts for three years and measures glucose in the blood. The device aims to eliminate the need for wearables and frequent sensor replacements.
Product Development, Medical Research, Healthcare Technology
Project
plans to start an OUS study in Melbourne, Australia, this quarter, and an IDE study in the U.S. early next year. The company anticipates potential commercial approval in later 2028 and launch near the end of that year.
Medical Research, Clinical Operations, Healthcare Technology
Project
Product Development, Medical Research, Healthcare Technology
GlucoTrack News & Media
Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
Submitted Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) to initiate a U.S. clinical study for fully implantable continuous blood glucose monitoring (CBGM) technologyGlucotrack Announces IDE Submission for U.S. Clinical Study of its Novel Implantable Continuous Blood Glucose Monitoring Technology
Submission supports advancement of a long‑term, fully implantable, blood‑based continuous glucose monitoring platform Submission supports advancement of a long‑term, fully implantable, blood‑based continuous glucose monitoring platformGlucotrack Announces Publication of Peer-Reviewed Study In The Journal of Diabetes Research Demonstrating Long-Term Accuracy and Stability of Continuous Blood Glucose Monitoring Technology
In-Vivo Ovine Study Demonstrates Sustained Performance Of Company’s Continuous Blood Glucose Monitoring (CBGM) Technology Over 240 Days, Reinforces Path to Key IDE Submission In-Vivo Ovine Study Demonstrates Sustained Performance Of Company’s Continuous Blood Glucose Monitoring (CBGM) Technology Over 240 Days, Reinforces Path to Key IDE SubmissionGlucotrack Announces Publication of Peer-Reviewed Study Supporting Long-Life Sensor Design for Implantable Continuous Blood Glucose Monitoring Technology
Year-long in-vitro characterization of glucose oxidase stability supports the feasibility of long-life implantable continuous glucose monitors, independent third party review of the longevity and functionality of design in the latter stage of in-human use Year-long in-vitro characterization of glucose oxidase stability supports the feasibility of long-life implantable continuous glucose monitors, independent third party review of the longevity and functionality of design in the latter stage of i
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding GlucoTrack
Sign Up For FreeTo access detailed company insights
GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. GlucoTra... Read More
